VanEck Associates
GEHC icon

VanEck Associates’s GE HealthCare GEHC Stock Holding History

VanEck Associates’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$287M Buy
4,482,631
+177,028
+4% +$11.6M 0.17% 88
2026
Q1 		$306M Sell
4,305,603
-87,023
-2% -$6.86M 0.23% 86
2025
Q4 		$360M Sell
4,392,626
-105,201
-2% -$8.2M 0.3% 68
2025
Q3 		$338M Buy
4,497,827
+139,404
+3% +$10.4M 0.31% 74
2025
Q2 		$323M Sell
4,358,423
-209,351
-5% -$14.6M 0.37% 62
2025
Q1 		$369M Sell
4,567,774
-273,878
-6% -$23.5M 0.48% 52
2024
Q4 		$379M Buy
4,841,652
+2,506,417
+107% +$213M 0.48% 56
2024
Q3 		$209M Buy
+2,335,235
New +$196M 0.26% 97
2024
Q2 		– Sell
-61,873
Closed -$5.63M – 1388
2024
Q1 		$5.63M Buy
61,873
+3,992
+7% +$332K 0.01% 542
2023
Q4 		$4.47M Buy
+57,881
New +$4.05M 0.01% 573

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

VanEck Associates's GEHC Position: Q2 2026 in Review

VanEck Associates increased its GE HealthCare (GEHC) stake by 4.1% in Q2 2026, buying an estimated $11.6M and bringing the position to 4,482,631 shares worth $287M. The position accounts for 0.17% of the portfolio, ranked #88.

VanEck Associates first reported a position in GEHC in Q4 2023 and has held it in 10 quarters since. The position peaked at $379M in Q4 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • VanEck Associates held 4,482,631 shares of GE HealthCare worth $287M as of Q2 2026.
  • VanEck Associates bought 177,028 GE HealthCare shares in Q2 2026, an estimated $11.6M.
  • GE HealthCare made up 0.17% of VanEck Associates's portfolio in Q2 2026, its #88 holding.
  • VanEck Associates first reported a position in GE HealthCare in Q4 2023 and has held it in 10 quarters since.
  • VanEck Associates's GE HealthCare position peaked at $379M in Q4 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.